Literature DB >> 12601114

CMT with pyramidal features. Charcot-Marie-Tooth.

S Vucic1, M Kennerson, D Zhu, E Miedema, C Kok, G A Nicholson.   

Abstract

To determine whether Charcot-Marie-Tooth (CMT) with pyramidal features is genetically distinct from other dominantly inherited axonal neuropathies, the authors examined all chromosomal loci and genes for axonal CMT. Two families were identified with an axonal CMT phenotype with distal wasting, weakness, pes cavus, sensory loss, and mild pyramidal signs (including extensor plantar responses, mild increase in tone, and preserved or increased reflexes but no spastic gait). Linkage studies excluded CMT2A, 2B, 2D, 2E, and 2F; ALS4; and HMN2. There were no mutations in the PMP22, MPZ/Po, or EGR2 genes.

Entities:  

Mesh:

Year:  2003        PMID: 12601114     DOI: 10.1212/01.wnl.0000048561.61921.71

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features.

Authors:  Roberta Biancheri; Federico Zara; Pasquale Striano; Marina Pedemonte; Denise Cassandrini; Silvia Stringara; Fiore Manganelli; Lucio Santoro; Angelo Schenone; Emilia Bellone; Carlo Minetti
Journal:  J Neurol       Date:  2006-04-10       Impact factor: 4.849

2.  A novel de novo MFN2 mutation causing CMT2A with upper motor neuron signs.

Authors:  S Ajroud-Driss; F Fecto; K Ajroud; Y Yang; S Donkervoort; N Siddique; T Siddique
Journal:  Neurogenetics       Date:  2009-04-07       Impact factor: 2.660

Review 3.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs.

Authors:  Obaid M Albulym; Marina L Kennerson; Matthew B Harms; Alexander P Drew; Anna H Siddell; Michaela Auer-Grumbach; Alan Pestronk; Anne Connolly; Robert H Baloh; Stephan Zuchner; Stephen W Reddel; Garth A Nicholson
Journal:  Ann Neurol       Date:  2016-01-13       Impact factor: 10.422

5.  Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations.

Authors:  Knut Brockmann; Steffi Dreha-Kulaczewski; Peter Dechent; Carsten Bönnemann; Gunther Helms; Marten Kyllerman; Wolfgang Brück; Jens Frahm; Kathrin Huehne; Jutta Gärtner; Bernd Rautenstrauss
Journal:  J Neurol       Date:  2008-04-21       Impact factor: 4.849

6.  The MFN2 V705I Variant Is Not a Disease-Causing Mutation: A Segregation Analysis in a CMT2 Family.

Authors:  Obaid M Albulym; Danqing Zhu; Stephen Reddel; Marina Kennerson; Garth Nicholson
Journal:  J Neurodegener Dis       Date:  2012-11-28

Review 7.  Mitofusin 2 Dysfunction and Disease in Mice and Men.

Authors:  Gerald W Dorn
Journal:  Front Physiol       Date:  2020-07-09       Impact factor: 4.566

8.  Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity.

Authors:  Małgorzata Beręsewicz; Łukasz Charzewski; Krystiana A Krzyśko; Andrzej Kochański; Barbara Zabłocka
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

9.  MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations.

Authors:  Haitian Nan; Takanori Hata; Toko Fukao; Toshimichi Fukao; Wanjing Chen; Takafumi Kurita; Takahiro Natori; Yoshihisa Takiyama
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.